rheumatology
2015 ACR/EULAR Gout Classification Criteria
2015 ACR/EULAR classification criteria for gout. Based on clinical, laboratory, and imaging evidence. Score ≥8 = gout classified. Gold standard = urate crystals in joint fluid, but scoring system available when unavailable.
References
- Neogi T et al. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2015;74(10):1789–1798.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Febuxostat (Rheumatology — Gout) · Xanthine Oxidase Inhibitor — Urate-Lowering Therapy
- Pegloticase (Recombinant PEGylated Uricase — Refractory Gout) · Recombinant Uricase — Urate-Lowering Biologic
- Colchicine (Acute Gout) · Anti-Inflammatory (Microtubule Inhibitor)
- Allopurinol · Xanthine Oxidase Inhibitor — Urate-lowering Therapy
- Febuxostat · Xanthine Oxidase Inhibitor — Urate-lowering Therapy
- Colchicine · Anti-Gout Agent
Pathways
- Cutaneous Lupus Erythematosus · BAD; EULAR
- Osteoporosis / Fragility Fracture · NOGG 2021; NICE NG147; NG224
- Arteritic AION (Giant Cell Arteritis) · RCOphth; BSR
- Osteoarthritis Hip / Knee Management · NICE NG226 (2022)
- Lupus Nephritis · EULAR/ERA-EDTA 2019; KDIGO 2024
- Rheumatoid Arthritis Management · NICE CG79 2018 / EULAR 2022
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.